
Tenofovir, Lamivudine And Efavirenz Tablets
| Product/Composition | Tenofovir, Lamivudine And Efavirenz Tablets |
|---|---|
| Strength | 300mg + 300mg + 600mg |
| Form | Tablets |
| Production Capacity | 10 Million Tablets/Month |
| Packaging | 30 Tablets/Bottle |
| Therapeutic use | Antiviral, Anti HIV |
| Package Insert/Leaflet | Available upon request |
Tenofovir, Lamivudine, and Efavirenz Tablets are a fixed-dose combination medicine widely used in the treatment of HIV-1 infection. This single-tablet regimen simplifies therapy by combining three antiretroviral drugs.
Here are the main details:
-
Main Uses:
-
Treatment of HIV-1 infection in adults and adolescents.
-
Helps reduce viral load and increase CD4 cell counts, improving immune function.
-
Lowers the risk of HIV-related complications and transmission when used consistently with other preventive measures.
-
-
How It Works:
-
Tenofovir disoproxil fumarate (TDF) – a nucleotide reverse transcriptase inhibitor (NtRTI) that blocks viral replication.
-
Lamivudine (3TC) – a nucleoside reverse transcriptase inhibitor (NRTI) that interferes with viral DNA synthesis.
-
Efavirenz (EFV) – a non-nucleoside reverse transcriptase inhibitor (NNRTI) that directly blocks the reverse transcriptase enzyme.
-
Together, they provide triple antiretroviral therapy, preventing the virus from multiplying.
-
-
Administration:
-
Taken once daily, usually at bedtime to reduce side effects such as dizziness.
-
Should be taken on an empty stomach, as food can increase side effects of efavirenz.
-
Important to take regularly at the same time to maintain drug levels.
-
-
Common Side Effects:
-
Dizziness, vivid dreams, or trouble sleeping (due to efavirenz).
-
Headache, nausea, diarrhea, or fatigue.
-
Skin rash (mild to moderate).
-
-
Serious Concerns:
-
Liver toxicity (monitor liver function).
-
Kidney function problems (mainly from tenofovir).
-
Bone density loss (associated with tenofovir).
-
Severe depression, anxiety, or psychiatric effects (from efavirenz in some patients).
-
Lactic acidosis and enlarged liver (rare but serious).
-
-
Precautions:
-
Not recommended during pregnancy unless benefits outweigh risks (efavirenz may cause harm in early pregnancy).
-
Should not be combined with other medicines containing tenofovir, lamivudine, or efavirenz.
-
Caution in patients with liver disease, kidney disease, or psychiatric disorders.
-
Regular monitoring of viral load, CD4 count, kidney and liver function is necessary.
-
-
Storage: Keep in a cool, dry place, away from moisture and direct light.
👉 This combination is a backbone therapy in HIV management because it provides a complete regimen in a single tablet, improving adherence and long-term viral suppression.